Roeland Vanhauwaert, PhDSenior Scientist at Argenx
Experienced neuroscientist specialized in neurodegeneration and neuromuscular biology. I obtained my PhD at KU Leuven/VIB Belgium (2017), followed by a 2 year post-doc at Stanford University. I’ve obtained competitive fellowship for both doctoral and post-doctoral. At Stanford University, I was responsible for translational research and drug discovery for neurodegenerative diseases, especially Parkinson’s disease. I was leading a small team, aiming to develop a partial Miro1 inhibitor to ultimately cure Parkinson’s disease. My research results are the foundation of a start-up company in Silicon Valley. Since 2019, I’m lead senior scientist for the ARGX-119 program at argenx.